Amarin and Lotus Pharmaceuticals Announce Exclusive Partners

Amarin and Lotus Pharmaceuticals Announce Exclusive Partnership Agreement to Commercialize Vazkepa® (Icosapent Ethyl) in Southeast Asia and South Korea

Amarin and Lotus Pharmaceuticals Announce Exclusive Partnership Agreement to Commercialize Vazkepa® (Icosapent Ethyl) in Southeast Asia and South Korea

einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Brazil , Indonesia , Philippines , Lotu , Sulawesi Selatan , Sweden , Vietnam , Republic Of , Thailand , Dublin , Ireland , Austria , Singapore , Cambodia , Japan , United Kingdom , Finland , Malaysia , Denmark , Brunei , Switzerland , China , New Jersey , United States , South Korea , Taiwan , Canada , Lebanon , United Arab Emirates , Great Britain , Scotland , Mark Marmur , Patrick Holt , Petar Vazharov , Amarin Corporation , Cerebrovascular Center , Lotus , European Union , Lotus Pharmaceuticals , Nasdaq , Exchange Commission , Collaboration Broadens Reach , Marketing Expertise , Southeast Asia , Southeast Asian Nations , Chief Executive Officer , Private Securities Litigation Reform Act , Securities Act , National Health Policy , Cardiovascular Disease , Regional Local Cardio Cerebrovascular Center , Korean Circulation Journal ,